COMMUNIQUÉS West-GlobeNewswire

Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
03/05/2018
LIVONIA, Mich., May 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
03/05/2018
Company Pursuing U.S. Vitaros Partnership and Strategic Alternatives SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company seeking to advance innovative [...]
AveXis Reports First Quarter 2018 Financial and Operating Results
03/05/2018
-- Significant progress across operating functions including licensing, clinical trials and regulatory interactions -- -- AVXS-101 pre-BLA meeting with FDA is scheduled to be held in June 2018 -- CHICAGO, May 03, 2018 ( [...]
Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies
03/05/2018
-- Sarepta strengthens position as a leader in gene therapy; expands rare disease franchise -- -- The program is designed, if successful, to offer first-ever corrective treatments for five distinct forms of Limb-girdle [...]
Sarepta Therapeutics Announces First Quarter 2018 Financial Results and Recent Corporate Developments
03/05/2018
-- First quarter 2017 EXONDYS 51 ® (eteplirsen) total net revenues of $64.6 million -- -- Sarepta signs exclusive partnership and buy-out option with Myonexus Therapeutics; pipeline expands from 16 to 21 programs -- -- [...]
Editas Medicine Announces First Quarter 2018 Results and Update
03/05/2018
Expanded Celgene collaboration to drive lead oncology program in solid tumors Strengthened Board of Directors with addition of James C. Mullen and Jessica Hopfield, Ph.D. Cash, cash equivalents, and marketable [...]
NewLink Genetics Reports First Quarter 2018 Financial Results
03/05/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, May 03, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the first quarter 2018 [...]
CRISPR Therapeutics to Participate in May Investor Conferences
03/05/2018
ZUG, Switzerland and CAMBRIDGE, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
IntelGenx to Report First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
03/05/2018
SAINT LAURENT, Quebec, May 03, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2018 financial results after market close on May [...]
Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
03/05/2018
Two Novel HBV Candidates Planned to Enter Clinical Development in 2018 GalNAc Conjugated RNAi Agent Nominated to Enter IND-Enabling Studies Strategic Partnership with Roivant to Launch Genevant, an RNA Therapeutics [...]
New Study Shows Robotic-Assisted Surgery Benefits for Inguinal Hernia Repair
03/05/2018
SUNNYVALE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Patients undergoing robotic-assisted surgery using a da Vinci Surgical System to repair an inguinal hernia had fewer complications after discharge through 30 days than [...]
American Academy of Dermatology Provides Tips for Skin Self-Exams
03/05/2018
Dermatologists encourage everyone to be a ‘Skin Cancer Hero’ by learning this life-saving behavior in conjunction with Skin Cancer Awareness Month and Melanoma Monday® ROSEMONT, Ill., May 03, 2018 (GLOBE NEWSWIRE) -- [...]
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers
03/05/2018
NANOBIOTIX PARTNERS WITH WEILL CORNELL MEDICINE ON PRE-CLINICAL STUDIES TO EVALUATE THE IMPACT OF NBTXR3 ON cGAS-STING PATHWAY IN MAMMARY CANCERS Paris, France and Cambridge, Massachusetts, USA, May 3, 2018 - NANOBIOTIX [...]
Nanobiotix et Weill Cornell Medecine s'associent autour d'un projet d'études non cliniques pour évaluer l'impact de NBTXR3 sur la voie cGAS-STING dans les cancers mammaires
03/05/2018
NANOBIOTIX ET WEILL CORNELL MEDECINE S'ASSOCIENT AUTOUR D'UN PROJET D'ETUDES NON CLINIQUES POUR EVALUER L'IMPACT DE NBTXR3 SUR LA VOIE cGAS-STING DANS LES CANCERS MAMMAIRES Paris, France et Cambridge, Massachusetts, USA [...]
Peak PACE Solutions to Join Capstone Performance Systems
03/05/2018
Acquisition will expand TRHC’s presence in PACE market ST. LOUIS, Mo. and MOORESTOWN, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ: TRHC ), a healthcare technology company offering comprehensive [...]
PotNetwork Holdings, Inc. and Family of Brands Featured in Financial Buzz, Born2Invest, Pet Business, International Business Times & Binary Deluxe; This Week in the News: A Curated Selection of the Best Media Coverage on PotNetwork Holdings, Inc.
03/05/2018
FT. LAUDERDALE, Fla., May 03, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holdings, Inc. (OTC Pink:POTN) On Wednesday April 25, 2018 PotNetwork Holdings, Inc. released its latest edition of: This Week in the [...]
Early Treatment Program for Opioid-Dependent Newborns Significantly Reduces Cost While Maintaining Medical and Safety Outcomes
03/05/2018
Study in June 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., May 03, 2018 (GLOBE NEWSWIRE) -- Prescription and non-prescription opioid use and dependence are increasing [...]
Mérieux Développement engage 20 millions d'euros dans Biobest
03/05/2018
Communiqué de presse Levée de fonds - Agriculture durable Mérieux Développement engage 20 millions d'euros dans Biobest, avec pour ambition d'établir la société en tant que leader de solutions naturelles de [...]
Mérieux Développement commits € 20 million into Biobest
03/05/2018
Growth Capital - Sustainable Agriculture Mérieux Développement commits € 20 million into Biobest, poised to become the global market leader in pollination and biological crop protection Lyon - May 3, 2018 - Mérieux [...]

Pages